Cargando…

Comparison of new forms of creatine in raising plasma creatine levels

BACKGROUND: Previous research has shown that plasma creatine levels are influenced by extracellular concentrations of insulin and glucose as well as by the intracellular creatine concentration. However, the form of creatine administered does not appear to have any effect although specific data on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Ralf, Harris, Roger C, Purpura, Martin, Francaux, Marc
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206055/
https://www.ncbi.nlm.nih.gov/pubmed/17997838
http://dx.doi.org/10.1186/1550-2783-4-17
_version_ 1782148439412310016
author Jäger, Ralf
Harris, Roger C
Purpura, Martin
Francaux, Marc
author_facet Jäger, Ralf
Harris, Roger C
Purpura, Martin
Francaux, Marc
author_sort Jäger, Ralf
collection PubMed
description BACKGROUND: Previous research has shown that plasma creatine levels are influenced by extracellular concentrations of insulin and glucose as well as by the intracellular creatine concentration. However, the form of creatine administered does not appear to have any effect although specific data on this is lacking. This study examined whether the administration of three different forms of creatine had different effects on plasma creatine concentrations and pharmacokinetics. METHODS: Six healthy subjects (three female and three male subjects) participated in the study. Each subject was assigned to ingest a single dose of isomolar amounts of creatine (4.4 g) in the form of creatine monohydrate (CrM), tri-creatine citrate (CrC), or creatine pyruvate (CrPyr) using a balanced cross-over design. Plasma concentration curves, determined over eight hours after ingestion, were subject to pharmacokinetic analysis and primary derived data were analyzed by repeated measures ANOVA. RESULTS: Mean peak concentrations and area under the curve (AUC) were significantly higher with CrPyr (17 and 14%, respectively) in comparison to CrM and CrC. Mean peak concentration and AUC were not significantly different between CrM and CrC. Despite the higher peak concentration with CrPyr there was no difference between the estimated velocity constants of absorption (ka) or elimination (kel) between the three treatments. There was no effect of treatment with CrPyr on the plasma pyruvate concentration. CONCLUSION: The findings suggest that different forms of creatine result in slightly altered kinetics of plasma creatine absorption following ingestion of isomolar (with respect to creatine) doses of CrM, CrC and CrPyr although differences in ka could not be detected due to the small number of blood samples taken during the absorption phase. Characteristically this resulted in higher plasma concentrations of creatine with CrPyr. Differences in bioavailability are thought to be unlikely since absorption of CrM is already close to 100%. The small differences in kinetics are unlikely to have any effect on muscle creatine elevation during periods of creatine loading.
format Text
id pubmed-2206055
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22060552008-01-18 Comparison of new forms of creatine in raising plasma creatine levels Jäger, Ralf Harris, Roger C Purpura, Martin Francaux, Marc J Int Soc Sports Nutr Research Article BACKGROUND: Previous research has shown that plasma creatine levels are influenced by extracellular concentrations of insulin and glucose as well as by the intracellular creatine concentration. However, the form of creatine administered does not appear to have any effect although specific data on this is lacking. This study examined whether the administration of three different forms of creatine had different effects on plasma creatine concentrations and pharmacokinetics. METHODS: Six healthy subjects (three female and three male subjects) participated in the study. Each subject was assigned to ingest a single dose of isomolar amounts of creatine (4.4 g) in the form of creatine monohydrate (CrM), tri-creatine citrate (CrC), or creatine pyruvate (CrPyr) using a balanced cross-over design. Plasma concentration curves, determined over eight hours after ingestion, were subject to pharmacokinetic analysis and primary derived data were analyzed by repeated measures ANOVA. RESULTS: Mean peak concentrations and area under the curve (AUC) were significantly higher with CrPyr (17 and 14%, respectively) in comparison to CrM and CrC. Mean peak concentration and AUC were not significantly different between CrM and CrC. Despite the higher peak concentration with CrPyr there was no difference between the estimated velocity constants of absorption (ka) or elimination (kel) between the three treatments. There was no effect of treatment with CrPyr on the plasma pyruvate concentration. CONCLUSION: The findings suggest that different forms of creatine result in slightly altered kinetics of plasma creatine absorption following ingestion of isomolar (with respect to creatine) doses of CrM, CrC and CrPyr although differences in ka could not be detected due to the small number of blood samples taken during the absorption phase. Characteristically this resulted in higher plasma concentrations of creatine with CrPyr. Differences in bioavailability are thought to be unlikely since absorption of CrM is already close to 100%. The small differences in kinetics are unlikely to have any effect on muscle creatine elevation during periods of creatine loading. BioMed Central 2007-11-12 /pmc/articles/PMC2206055/ /pubmed/17997838 http://dx.doi.org/10.1186/1550-2783-4-17 Text en Copyright © 2007 Jäger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Jäger, Ralf
Harris, Roger C
Purpura, Martin
Francaux, Marc
Comparison of new forms of creatine in raising plasma creatine levels
title Comparison of new forms of creatine in raising plasma creatine levels
title_full Comparison of new forms of creatine in raising plasma creatine levels
title_fullStr Comparison of new forms of creatine in raising plasma creatine levels
title_full_unstemmed Comparison of new forms of creatine in raising plasma creatine levels
title_short Comparison of new forms of creatine in raising plasma creatine levels
title_sort comparison of new forms of creatine in raising plasma creatine levels
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206055/
https://www.ncbi.nlm.nih.gov/pubmed/17997838
http://dx.doi.org/10.1186/1550-2783-4-17
work_keys_str_mv AT jagerralf comparisonofnewformsofcreatineinraisingplasmacreatinelevels
AT harrisrogerc comparisonofnewformsofcreatineinraisingplasmacreatinelevels
AT purpuramartin comparisonofnewformsofcreatineinraisingplasmacreatinelevels
AT francauxmarc comparisonofnewformsofcreatineinraisingplasmacreatinelevels